Microplastic Detection Market

The  Microplastic Detections market size is projected to grow from USD  4.76 billion in 2024 to USD  6.49 billion by 2029, registering a CAGR of 6.4% during the forecast period. The Microplastic Detections market is experiencing robust growth due to several key factors and opportunities. The primary factor is increased awareness of the detrimental effects of microplastic pollution towards the environment and health. Microplastics are detected in a number of ecosystems including soil, water, and air that will potentially threaten marine life and its food chain. This has raised public concern and elevated pressure on the government for establishing strict rules and regulations. Manufacturing, textile, and packing industries adopt these technologies to comply with the regulations. Furthermore, advancements in technology have made detection method more accurate and efficient.

These prominent competitors, along with a slew of others, define the Microplastic Detections market through ongoing innovation, strategic partnership, acquistion and worldwide growth strategies. Their contributions propel technological developments, broaden market reach, and shape industry standards, ultimately influencing the future of Microplastic Detections and their numerous uses., such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Bruker (US), PerkinElmer (US), JEOL Ltd. (Japan), Shimadzu Corporation (Japan), Oxford Instruments (UK), Endress+Hauser Group Services AG (Switzerland), Danaher Corporation (US), METTLER TOLEDO (Switzerland), ZEISS Group (Germany) adopt  acquisitions, product launches and expansions  to increase their market shares and expand their geographic presence.

To know about the assumptions considered for the study download the pdf brochure

Agilent Technologies, Inc., founded in 1999, is a prominent player in the life sciences, diagnostics, and applied chemical markets headquartered in California, US. The company offers advanced technology for detecting microplastics in environments. Agilent Technologies operates through three core business segments: Life Sciences and Applied Markets business, Diagnostics and Genomics business, and Agilent CrossLab business. The Life Sciences and Applied Markets segment delivers application-focused solutions that include instruments, consumables, and software designed to help customers identify, quantify, and analyze the physical and biological properties of various substances and products. The product offerings feature liquid chromatography (LC) systems and components, gas chromatography (GC) systems and components, gas chromatography mass spectrometry (GCMS) systems, inductively coupled plasma mass spectrometry (ICP-MS) instruments, atomic absorption (AA) instruments, liquid chromatography mass spectrometry (LCMS) systems, microwave plasma-atomic emission spectrometry (MP-AES) instruments, laboratory automation and robotic systems, dissolution testing, as well as vacuum pumps and measurement technologies. The company has a substantial presence, with manufacturing facilities in Europe, North America, South Americas, Asia Pacific, and direct service delivery organizations in 29 countries. Agilent Technologies, Inc. categorizes its revenue into three regions: the Americas, Europe, and Asia Pacific. In 2023, the Americas accounted for the highest share of sales at 40%, followed by the Asia Pacific at 34.3%, and Europe at 25.7%.

Bruker is a leading provider of scientific instruments and analytical solutions established in 1960 and headquartered in Massachusetts, USA. The company categorizes its business activities into four distinct segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST). The BSI CALID segment includes the Bruker Life Sciences Mass Spectrometry, Bruker Applied Mass Spectrometry, Bruker Microbiology and Diagnostics, and Bruker Optics divisions. The segment specializes in solutions for life sciences, including mass spectrometry and ion mobility spectrometry, as well as analytical and process analysis instruments. It also offers solutions utilizing infrared and Raman molecular spectroscopy to detect microplastic, as well as radiological and nuclear detectors designed to detect chemical, biological, radiological, nuclear, and explosive threats. The company has a vast global presence with 14 manufacturing facilities in Europe, North America and Southeast Asia, and sales offices throughout the world. Bruker categorizes its revenue into four regions: United States, Europe, Asia Pacific, and the Rest of the World. In 2023, the Asia Pacific accounted for the largest share of the sales at 33.4%, followed by Europe at 33.1%, United States at 26.2%, and the Rest of the World at 7.3%.

Shimadzu Corporation, founded in 1875, is a prominent Japanese manufacturer of precision instruments headquartered in Kyoto, Japan. The company operates primarily through five business segments: Analytical and Measuring Instruments, Medical Systems, Industrial Machinery, Aircraft Equipment, and Other. Shimadzu's Analytical and Measuring Instruments sector offers a wide range of products, including gas and liquid chromatography, gas chromatograph-mass spectrometry, liquid chromatograph-mass spectrometry, and data management software for microplastic detection purposes. Its product offerings include life science laboratory instruments, total organic carbon analysis, continuous monitoring analysis, thermal analysis, particle size analysis, materials testing and inspection, non-destructive testing, and balances. These instruments serve various sectors, including ceramics, metals & mining, clinical & forensics, electronics, food & beverages, mechanical & automotive, petrochemical & chemical, as well as pharmaceutical and life sciences.  In 2022, the Analytical and Measuring Instruments segment accounted for 65 % of the company's total revenue, while Medical Systems accounted for 16%, Industrial Machinery contributed 13%, Aircraft Equipment represented 5%, and other businesses made up 1%. The company has a vast global presence in North America, South America, Europe, Asia Pacific, and Middle East & Africa with 17 production locations: 8 in Japan and 9 overseas

PerkinElmer is an American global corporation founded in 1937 with headquarters in Shelton, US. It operates through two reportable business segments: Discovery & Analytical Solutions and Diagnostics. PerkinElmer 's Discovery & Analytical Solutions division specializes in the microplastic detection technology. The segment caters to the life sciences and applied markets. In the life sciences market, the segment provides a range of solutions including reagents, informatics, and detection and imaging technologies. Whereas its major products in the applied markets include gas chromatographs, gas chromatographs/mass spectrometers, ultra-high performance liquid chromatography (UHPLC), Flexar advanced liquid chromatography systems, flow-based mass spectrometry system, atomic absorption spectrometers, infrared spectroscopy, milk quality analyzers, and test kits. PerkinElmer boasts an impressive portfolio of 100,000 active instruments deployed across the globe and its vast reach in the scientific community. With three strategically located global distribution and manufacturing facilities in the Americas, Europe, and Asia, PerkinElmer effectively meets the diverse needs of its customer base. The company operates 75 offices across the globe, enabling it to serve clients in 168 countries.

Danaher Corporation is prominent American global conglomerate specializing in the design, manufacturing, and marketing of medical, industrial, and commercial products and services, founded in 1984, and headquartered in Washington, D.C., US. The company functions through three distinct reportable business segments: Biotechnology, Life Sciences, and Diagnostics. Danaher provides the microplastic detection technology through its Life Sciences segment. The segment encompasses a diverse range of instruments, consumables, services, and software primarily utilized by customers to explore genomics and the fundamental components of life, such as DNA, RNA, nucleic acids, proteins, metabolites, and cells. It comprises several businesses, including Flow Cytometry and Lab Automation Solutions, Mass Spectrometry, Microscopy, Protein Consumables, Industrial Filtration, and Genomic Medicines. Danaher manufactures the CytoFLEX flow cytometer under its Beckman Coulter Life Sciences brand. The company operates facilities in more than 50 countries, comprising approximately 184 key administrative, sales, research & development, manufacturing, and distribution sites. Of these, 70 facilities are situated in the US across more than 20 states, while 114 are located internationally, primarily in Europe, with other facilities in Asia, Australia, Canada, and South America.

Related Reports:

Microplastic Detection Market by Type (Polyethylene, Polytetrafluoroethylene), technology (Micro-Raman Spectroscopy, Ftir Spectroscopy), Medium (Water, Soil), Size ( < 1mm, 1-3mm), End-Use Industry (Water Treatment, FnB) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]